Companies: 10,795·Total market cap: $144.5T
Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4359
P/E Ratio
52W High$0.0001
52W Low$0.00001

Baudax Bio, Inc. (BXRXQ) Revenue

Annual & quarterly revenue history · segment & region breakdown

BXRXQ · revenue · updated Jun 10, 2026

Core revenue metrics

Baudax Bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.01×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$34K
9 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Baudax Bio, Inc. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
BXRXQ revenue by year · BXRXQ revenue history · BXRXQ annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Baudax Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Baudax Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Baudax Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

BXRXQ revenue · 4 questions

BXRXQ's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

BXRXQ revenueBXRXQ annual revenuewhat is BXRXQ revenueBXRXQ TTM revenue

Source: FMP · Baudax Bio, Inc. SEC filings · GAAP · Baudax Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026